© 2024 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
In this special edition of the CURE Talks Cancer podcast, we kick off National Hereditary Breast and Ovarian Cancer Week and Previvor Day.
In 2010, history was made when a Congressional resolution was passed to declare the first-ever National Hereditary Breast and Ovarian Cancer Week and National Previvor Day to raise awareness about hereditary cancer.
Millions of people carry an inherited mutation or have a family history of cancer but many don't know about their risk. National Hereditary Breast and Ovarian Cancer Week and Previvor Day aim to change that.
In this special edition of the CURE Talks Cancer, we spoke with president and CEO of My Gene Counsel, Ellen Matloff, and founder of Proactive Genes, Shannon Pulaski, to help kick off National Hereditary Breast and Ovarian Cancer Week and Previvor Day. In this episode you’ll hear about their resources and how each can help others learn more about their hereditary risk.
Related Content: